Wire · opportunities
CG MedTech's H1 sales grow, but consolidated operating profit tumbles |
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 August 2026 · Fusion42 review
CG MedTech reported a 35.1% increase in standalone sales driven by orthopedic and dental implants, but consolidated operating profit dropped 77.2% due to costs from newly consolidated subsidiaries and business expansion. The company expanded production capacity with a new automated plant and advanced its digital dentistry and regenerative medicine segments, aiming for 100 billion won annual sales by 2028.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Your medical device business now faces higher scale demands and upfront costs as CG MedTech ramps automated production and digital dentistry capabilities. Prepare to compete where established companies extend control over manufacturing and regenerative medicine supply chains.
◆ Coverage
1 source · 21 Aug 2026
◆ Related on Wire
◆ Topics